These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 21557838)
1. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. El Fegoun AB; Barret E; Prapotnich D; Soon S; Cathelineau X; Rozet F; Galiano M; Sanchez-Salas R; Vallancien G Int Braz J Urol; 2011; 37(2):213-9; discussion 220-2. PubMed ID: 21557838 [TBL] [Abstract][Full Text] [Related]
3. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer. Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616 [TBL] [Abstract][Full Text] [Related]
4. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508 [TBL] [Abstract][Full Text] [Related]
5. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation. von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211 [TBL] [Abstract][Full Text] [Related]
7. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. Thüroff S; Chaussy C J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962 [TBL] [Abstract][Full Text] [Related]
8. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. Pfeiffer D; Berger J; Gross AJ BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703 [TBL] [Abstract][Full Text] [Related]
9. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center. Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332 [TBL] [Abstract][Full Text] [Related]
10. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. Rebillard X; Soulié M; Chartier-Kastler E; Davin JL; Mignard JP; Moreau JL; Coulange C; BJU Int; 2008 May; 101(10):1205-13. PubMed ID: 18325057 [TBL] [Abstract][Full Text] [Related]
11. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Blana A; Walter B; Rogenhofer S; Wieland WF Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475 [TBL] [Abstract][Full Text] [Related]
12. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response. Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405 [TBL] [Abstract][Full Text] [Related]
13. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. Ficarra V; Antoniolli SZ; Novara G; Parisi A; Fracalanza S; Martignoni G; Artibani W BJU Int; 2006 Dec; 98(6):1193-8. PubMed ID: 17125477 [TBL] [Abstract][Full Text] [Related]
14. High-intensity focused ultrasound therapy for clinically localized prostate cancer. Lee HM; Hong JH; Choi HY Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468 [TBL] [Abstract][Full Text] [Related]
15. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses. Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782 [TBL] [Abstract][Full Text] [Related]
16. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750 [TBL] [Abstract][Full Text] [Related]
17. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199 [TBL] [Abstract][Full Text] [Related]
18. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708 [TBL] [Abstract][Full Text] [Related]
19. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results. Berge V; Baco E; Karlsen SJ Scand J Urol Nephrol; 2010 Sep; 44(4):223-7. PubMed ID: 20350272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]